Inspire Medical系統 INSP 深 滬
已收盤 01-09 16:00:00 美东时间
98.38
+3.380
+3.56%
華盛通- 最 高102.645
- 今 開97.29
- 成交量 169.66万股
- 最 低 96.56
- 昨 收 95.00
- 總市值 29.10亿
- 52周最高 203.12
- 市盈率 靜 56.16
- 換手率 0.01%
- 52周最低 70.77
- 委 比 4.35%
- 總股本 2957.43万
- 歷史最高 330.00
- 量 比 1.54
- 振 幅 6.41%
- 歷史最低 22.50
- 每 手 1
- 風險率 38.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
Inspire Medical Systems will release its Q4 and full-year 2025 financial results on February 11, followed by a conference call at 5:00 p.m. ET. A webcast will be available for listening, and participants wanting to ask questions must register in advance. The call will be replayed on the Investor Relations website approximately two hours after the event and archived for two weeks.
01-07 13:00
Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Inspire Medical Systems to present at J.P. Morgan Healthcare Conference on January 12, 2026, discussing its innovative minimally invasive solutions for obstructive sleep apnea. The live webcast will be available at the provided link, and a replay will be accessible on their Investor website for two weeks post-presentation.
2025-12-29 13:00
美股大行评级 | 潜在涨幅63.56%！拜玛林制药获Truist Securities升目标价至100美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持拜玛林制药"买入"评级，目标价从80美元升至100美元；HC Wainwright & Co.：维持Savara"买入"评级，目标价从8美元升至10美元
2025-12-24 11:17
美股周涨跌榜 | 特朗普媒体科技集团周涨51.1%，拟并购TAE转型聚变能源公司；Medline周涨43.6%
DJT周涨51.1%，拟并购TAE转型聚变能源公司；Medline周涨43.6%，本周首挂上市，为年内全球最大规模IPO；爱美医疗周涨34.4%，获拜玛林制药48亿美元收购>>
2025-12-20 09:40
Trump Media Soars 34%, Tech Stocks Rally As Inflation Drops: What's Moving Markets Thursday?
Screens across Wall Street turned green Thursday as risk appetite snapped back after a cooler-than-expected inflation report revived hopes for rate cuts and a blowout earnings outlook from Micron Technology Inc.
2025-12-19 02:40
Inspire Medical slides after Medicare reimbursement policy change
Inspire Medical Systems (INSP) lost ~18% on Thursday in a move attributed to a significant policy shift from Medicare administrator contractors Noridian and CGS that could impact reimbursements for th...
2025-12-19 00:45
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $118
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $82 to $118.
2025-12-16 23:59
